Notify me when John Robert Wilson files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| MRKR | Marker Therapeutics, Inc. | Common Stock, Par Value $0.001 | 5% | 641,801 | -2.7% | John R. Wilson TTE, John R. Wilson Revocable Trust U/A DTD 08/03/2017 | 19 Aug 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|